In the near future, the Immunohistochemistry (IHC) industry is poised to undergo transformative advancements that will redefine diagnostic and research capabilities in the field of pathology and biology. With ongoing developments in antibody technology, automation, and image analysis, IHC techniques will become more precise, efficient, and accessible. Personalized medicine will benefit from...